Covered recipient · General Payments record
JUDAH D PIFER
Allopathic & Osteopathic Physicians Orthopaedic Surgery Foot and Ankle Surgery
General Payments · PY2018–2024
$896.04
- Reported across 48 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $309.84 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| BAXTER HEALTHCARE | $55.84 | 3 |
| Stryker Corporation | $42.35 | 1 |
| FIDIA PHARMA USA INC. | $37.66 | 2 |
| Vericel Corporation | $33.57 | 2 |
| Smith & Nephew, Inc. | $32.28 | 1 |
| Abbott Laboratories | $28.19 | 1 |
| Bioventus LLC | $23.18 | 1 |
| Ferring Pharmaceuticals Inc. | $22.78 | 1 |
| OsteoCentric Technologies, Inc. | $18.45 | 1 |
| Amgen Inc. | $15.54 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $28.19 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125041562 | CMS |
| Amgen Inc. | $15.54 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111677165 | CMS |
| Baxter Healthcare | $21.32 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118289409 | CMS |
| Baxter Healthcare | $13.81 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118289412 | CMS |
| Baxter Healthcare | $20.71 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118289415 | CMS |
| Bioventus LLC | $23.18 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137447303 | CMS |
| Ferring Pharmaceuticals Inc. | $22.78 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137503072 | CMS |
| Fidia Pharma USA Inc. | $18.11 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141158491 | CMS |
| Fidia Pharma USA Inc. | $19.55 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141158493 | CMS |
| OsteoCentric Technologies, Inc. | $18.45 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113868016 | CMS |
| Smith+Nephew, Inc. | $32.28 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149541531 | CMS |
| Stryker Corporation | $42.35 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119945876 | CMS |
| Vericel Corporation | $17.24 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128574706 | CMS |
| Vericel Corporation | $16.33 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128574708 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.